{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:45:26Z","timestamp":1782902726164,"version":"3.54.5"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["112001-1"],"award-info":[{"award-number":["112001-1"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["112001"],"award-info":[{"award-number":["112001"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC112A03"],"award-info":[{"award-number":["KMU-TC112A03"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KT112P002"],"award-info":[{"award-number":["KT112P002"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2320-B-037-011-MY3"],"award-info":[{"award-number":["NSTC 112-2320-B-037-011-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2124-M-037-001 -"],"award-info":[{"award-number":["NSTC 112-2124-M-037-001 -"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2314-B-037 -051 -MY3"],"award-info":[{"award-number":["111-2314-B-037 -051 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2124-M-037-001"],"award-info":[{"award-number":["111-2124-M-037-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2320-B-037 -010 -MY3"],"award-info":[{"award-number":["110-2320-B-037 -010 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung Ho Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004725","name":"Ministry of Economic Affairs","doi-asserted-by":"publisher","award":["112-EC-17-A-17-S6-021"],"award-info":[{"award-number":["112-EC-17-A-17-S6-021"]}],"id":[{"id":"10.13039\/501100004725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijbiomac.2025.140138","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:23:12Z","timestamp":1737339792000},"page":"140138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG\u00d7EphA2 increases therapeutic efficacy against lung cancer"],"prefix":"10.1016","volume":"300","author":[{"given":"Kai-Wen","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ting","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-Shuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lin","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Mae","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve R.","family":"Roffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijbiomac.2025.140138_bb0005","article-title":"Monitoring EPR effect dynamics during nanotaxane treatment with theranostic polymeric micelles","volume":"9","author":"Biancacci","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12951-022-01644-x","article-title":"Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity","volume":"20","author":"Shim","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijbiomac.2022.03.139","article-title":"Tumor-targeted hyaluronic acid-based oxidative stress nanoamplifier with ROS generation and GSH depletion for antitumor therapy","volume":"207","author":"Liu","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jconrel.2013.10.001","article-title":"Questions on the role of the EPR effect in tumor targeting","volume":"172","author":"Park","year":"2013","journal-title":"Journal of controlled release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2014.03.057","article-title":"EPR: evidence and fallacy","volume":"190","author":"Nichols","year":"2014","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140138_bb0030","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1021\/acsnano.9b08142","article-title":"Meta-analysis of nanoparticle delivery to tumors using a physiologically based pharmacokinetic modeling and simulation approach","volume":"14","author":"Cheng","year":"2020","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140138_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140138_bb0040","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.140138_bb0045","doi-asserted-by":"crossref","first-page":"14080","DOI":"10.1021\/acsnano.1c04510","article-title":"Specific endothelial cells govern nanoparticle entry into solid tumors","volume":"15","author":"Kingston","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0050","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ijbiomac.2019.10.026","article-title":"A biodegradable multifunctional porous microsphere composed of carrageenan for promoting imageable trans-arterial chemoembolization","volume":"142","author":"Kunliang","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00280-006-0340-4","article-title":"Effect of pH and human serum albumin on the cytotoxicity of a glucuronide prodrug of 9-aminocamptothecin","volume":"60","author":"Prijovich","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140138_bb0060","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ejps.2013.06.005","article-title":"Kinetic and thermodynamic studies of 9-aminocamptothecin hydrolysis at physiological pH in the presence of human serum albumin","volume":"49","author":"Patel","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140138_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0070","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41467-018-04225-5","article-title":"Reversible glycosidic switch for secure delivery of molecular nanocargos","volume":"9","author":"Burnouf","year":"2018","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.140138_bb0075","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.140138_bb0080","article-title":"Polyethylene glycol-like brush polymer conjugate of a protein drug does not induce an Antipolymer immune response and has enhanced pharmacokinetics than its polyethylene glycol counterpart","volume":"9","author":"Ozer","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140138_bb0085","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.7150\/ijbs.46194","article-title":"MFP-FePt-GO nanocomposites promote radiosensitivity of non-small cell lung cancer via activating mitochondrial-mediated apoptosis and impairing DNA damage repair","volume":"16","author":"Peng","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"37","key":"10.1016\/j.ijbiomac.2025.140138_bb0090","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1016\/j.biomaterials.2014.08.032","article-title":"One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles","volume":"35","author":"Kao","year":"2014","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.140138_bb0095","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1039\/C9BM00323A","article-title":"Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer","volume":"7","author":"Cheng","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0100","doi-asserted-by":"crossref","first-page":"15507","DOI":"10.1038\/ncomms15507","article-title":"Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy","volume":"8","author":"Su","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12951-020-00752-w","article-title":"Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity","volume":"19","author":"Ho","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"696","key":"10.1016\/j.ijbiomac.2025.140138_bb0110","doi-asserted-by":"crossref","first-page":"eabm1262","DOI":"10.1126\/scitranslmed.abm1262","article-title":"Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia","volume":"15","author":"Moles","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0115","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1080\/10717544.2018.1466936","article-title":"Bispecific antibodies (anti-mPEG\/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors","volume":"25","author":"Su","year":"2018","journal-title":"Drug Deliv."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.140138_bb0120","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1002\/anie.201814665","article-title":"Engineering polymer-binding bispecific antibodies for enhanced pretargeted delivery of nanoparticles to mucus-covered epithelium","volume":"58","author":"Huckaby","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13045-020-00944-9","article-title":"Targeting EphA2 in cancer","volume":"13","author":"Xiao","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0130","first-page":"79","article-title":"c-Cbl-dependent EphA2 protein degradation is induced by ligand binding","volume":"1","author":"Walker-Daniels","year":"2002","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.140138_bb0135","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.7150\/ijbs.82567","article-title":"Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer","volume":"19","author":"Zhao","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140138_bb0140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1158\/0008-5472.CAN-15-0717","article-title":"EPHA2 blockade overcomes acquired resistance to EGFR kinase inhibitors in lung cancer","volume":"76","author":"Amato","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140138_bb0145","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/1535-7163.MCT-18-0539","article-title":"EPHA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer","volume":"18","author":"Martini","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140138_bb0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.22415","article-title":"EphA2 overexpression is associated with angiogenesis in ovarian cancer","volume":"109","author":"Lin","year":"2007","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.140138_bb0155","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.21873\/anticanres.13834","article-title":"Elevated expression of EPHA2 is associated with poor prognosis after radical prostatectomy in prostate cancer","volume":"39","author":"Kurose","year":"2019","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140138_bb0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s13402-020-00511-x","article-title":"Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level","volume":"43","author":"Mo","year":"2020","journal-title":"Cell. Oncol. (Dordr.)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140138_bb0165","first-page":"613","article-title":"Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival","volume":"9","author":"Kinch","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140138_bb0170","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/ijc.31405","article-title":"EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma","volume":"143","author":"Garcia-Monclus","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140138_bb0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1165\/ajrcmb.17.3.2837","article-title":"Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line","volume":"17","author":"Chu","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12951-020-00680-9","article-title":"Humanized bispecific antibody (mPEG x HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer","volume":"18","author":"Cheng","year":"2020","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/bios5010098","article-title":"Label-free detection of rare cell in human blood using gold nano slit surface plasmon resonance","volume":"5","author":"Mousavi","year":"2015","journal-title":"Biosensors (Basel)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140138_bb0190","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1021\/bc050133f","article-title":"Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles","volume":"16","author":"Cheng","year":"2005","journal-title":"Bioconjug. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.140138_bb0195","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1021\/bc100067t","article-title":"Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies","volume":"21","author":"Su","year":"2010","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140138_bb0200","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jssc.201301191","article-title":"Versatile online SPE-HPLC method for the analysis of irinotecan and its clinically relevant metabolites in biomaterials","volume":"37","author":"Prijovich","year":"2014","journal-title":"J. Sep. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.140138_bb0205","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines-lessons learned from successes and failures","volume":"52","author":"He","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0210","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1038\/s41598-023-30950-z","article-title":"A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer","volume":"13","author":"Mamot","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0215","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12951-021-00846-z","article-title":"Dual activity of PD-L1 targeted doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model","volume":"19","author":"Merino","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140138_bb0220","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.7150\/ijbs.78248","article-title":"IFNgamma blockade in capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial-cadherins","volume":"19","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"12 Pt 1","key":"10.1016\/j.ijbiomac.2025.140138_bb0225","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.140138_bb0230","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.140138_bb0235","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1021\/acsnano.7b07214","article-title":"New insights into \u201cpermeability\u201d as in the enhanced permeability and retention effect of cancer nanotherapeutics","volume":"11","author":"Nel","year":"2017","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.140138_bb0240","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1021\/nn500299p","article-title":"Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency","volume":"8","author":"Sykes","year":"2014","journal-title":"ACS Nano"},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.140138_bb0245","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","article-title":"Active targeting schemes for nanoparticle systems in cancer therapeutics","volume":"60","author":"Byrne","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0250","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ijbiomac.2021.06.191","article-title":"Advances in antibody nanoconjugates for diagnosis and therapy: a review of recent studies and trends","volume":"185","author":"Kadkhoda","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.140138_bb0255","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-05-4199","article-title":"Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models","volume":"66","author":"Kirpotin","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-021-01311-z","article-title":"mRNA vaccine: a potential therapeutic strategy","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0265","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.actbio.2023.07.008","article-title":"Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer","volume":"168","author":"Huang","year":"2023","journal-title":"Acta Biomater."},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2025.140138_bb0270","article-title":"Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: a comprehensive review","volume":"267","author":"Pawar","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0275","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.msec.2014.10.043","article-title":"Applications of nanoparticles in treatment and diagnosis of leukemia","volume":"47","author":"Soni","year":"2015","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.140138_bb0280","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1021\/acsami.0c17121","article-title":"Aptamer-functionalized micro- and nanocarriers for controlled release","volume":"13","author":"Vazquez-Gonzalez","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110582","article-title":"Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19","volume":"130","author":"Norinder","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.140138_bb0290","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.tibtech.2023.05.007","article-title":"Rise of the RNA machines - self-amplification in mRNA vaccine design","volume":"41","author":"Comes","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0295","article-title":"Development and delivery systems of mRNA vaccines","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140138_bb0300","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1423-0127-20-54","article-title":"Cysteine-rich domain of scavenger receptor AI modulates the efficacy of surface targeting and mediates oligomeric Abeta internalization","volume":"20","author":"Huang","year":"2013","journal-title":"J. Biomed. Sci."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.140138_bb0305","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/jnci\/djj414","article-title":"Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer","volume":"98","author":"Landen","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.140138_bb0310","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.21873\/anticanres.12592","article-title":"An agonistic antibody to EPHA2 exhibits antitumor effects on human melanoma cells","volume":"38","author":"Sakamoto","year":"2018","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.140138_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12100996","article-title":"Targeting EphA2 in bladder cancer using a novel antibody-directed nanotherapeutic","volume":"12","author":"Kamoun","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140138_bb0320","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.synbio.2020.05.004","article-title":"A high stable pH-temperature dual-sensitive liposome for tuning anticancer drug release","volume":"5","author":"Zhao","year":"2020","journal-title":"Synth. Syst. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118605","article-title":"EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers","volume":"569","author":"Matusewicz","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0330","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2015.05.284","article-title":"Immunoliposome-mediated drug delivery to plasmodium-infected and non-infected red blood cells as a dual therapeutic\/prophylactic antimalarial strategy","volume":"210","author":"Moles","year":"2015","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.140138_bb0335","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.1912012117","article-title":"Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier","volume":"117","author":"Marcos-Contreras","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0340","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejpb.2018.09.017","article-title":"Sortaggable liposomes: evaluation of reaction conditions for single-domain antibody conjugation by Sortase-A and targeting of CD11b(+) myeloid cells","volume":"133","author":"Woll","year":"2018","journal-title":"European journal of pharmaceutics and biopharmaceutics\u202f: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.ijbiomac.2025.140138_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109923","article-title":"Biotin-targeted mixed liposomes: a smart strategy for selective release of a photosensitizer agent in cancer cells","volume":"104","author":"de Freitas","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025006877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025006877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:02:42Z","timestamp":1782900162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025006877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":69,"alternative-id":["S0141813025006877"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140138","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG\u00d7EphA2 increases therapeutic efficacy against lung cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"140138"}}